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Abstract
Background: Malaria prevalence has recently declined markedly in many parts of Tanzania and other sub-Saharan
African countries due to scaling-up of control interventions including more efficient treatment regimens (e.g.
artemisinin-based combination therapy) and insecticide-treated bed nets. Although continued molecular surveillance of
malaria parasites is important to early identify emerging anti-malarial drug resistance, it is becoming increasingly difficult
to obtain parasite samples from ongoing studies, such as routine drug efficacy trials. To explore other sources of
parasite DNA, this study was conducted to examine if sufficient DNA could be successfully extracted from malaria rapid
diagnostic tests (RDTs), used and collected as part of routine case management services in health facilities, and thus
forming the basis for molecular analyses, surveillance and quality control (QC) testing of RDTs.
Methods: One hyper-parasitaemic blood sample (131,260 asexual parasites/μl) was serially diluted in triplicates with
whole blood and blotted on RDTs. DNA was extracted from the RDT dilution series, either immediately or after
storage for one month at room temperature. The extracted DNA was amplified using a nested PCR method for
Plasmodium species detection. Additionally, 165 archived RDTs obtained from ongoing malaria studies were
analysed to determine the amplification success and test applicability of RDT for QC testing.
Results: DNA was successfully extracted and amplified from the three sets of RDT dilution series and the minimum
detection limit of PCR was <1 asexual parasite/μl. DNA was also successfully amplified from (1) 70/71 (98.6%)
archived positive RDTs (RDTs and microscopy positive) (2) 52/63 (82.5%) false negative RDTs (negative by RDTs but
positive by microscopy) and (3) 4/24 (16.7%) false positive RDTs (positive by RDTs but negative by microscopy).
Finally, 7(100%) negative RDTs (negative by RDTs and microscopy) were also negative by PCR.
Conclusion: This study showed that DNA extracted from archived RDTs can be successfully amplified by PCR and
used for detection of malaria parasites. Since Tanzania is planning to introduce RDTs in all health facilities (and
possibly also at community level), availability of archived RDTs will provide an alternative source of DNA for genetic
studies such as continued surveillance of parasite resistance to anti-malarial drugs. The DNA obtained from RDTs
can also be used for QC testing by detecting malaria parasites using PCR in places without facilities for microscopy.
Background
Malaria has for a long time remained a major cause of
morbidity and mortality in most endemic countries par-
ticularly in sub-Saharan Africa. However, recent reports
have indicated that malaria prevalence has declined
drastically in some endemic countries [1-4]. The decline
has also been reported in most areas of Tanga region,
which was a malaria hyper-endemic area until recently
[5] and possibly other parts of Tanzania (National
Malaria Control Programme, unpublished data). The
declining malaria in Tanga, Tanzania and other coun-
tries is possibly attributed to more efficient treatment
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regimens (using artemisinin combination therapy, ACT)
and increased availability and use of insecticide-impreg-
nated bed nets[4].
Following changes of malaria treatment guidelines in
Tanzania in 2006, by introducing an ACT containing
artemether and lumefantrine (ALu) [6], which is rela-
tively expensive compared to other drugs that were pre-
viously used in the country, it is rationally
recommended that ALu should be prescribed to only
laboratory confirmed cases [7,8]. However, laboratory
services are not available in most parts of Tanzania,
especially in rural areas and in places with laboratory
facilities, the quality of malaria diagnosis is generally
poor [9,10] or the results are often ignored by clinicians
[11]. Thus, the Tanzanian Ministry of Health and Social
Welfare through the National Malaria Control Pro-
gramme (NMCP) is planning to introduce rapid diag-
nostic tests (RDTs) in all health facilities to scale-up
malaria diagnosis and improve case management.
RDTs detect presence of parasite specific antigens and
available RDTs detect either Plasmodium falciparum
specific histidine rich protein 2 (PfHRP-2), Plasmodium
lactate dehydrogenase (pLDH) or aldolase [12-14]. Most
of the available tests usually involve blotting a small
volume of blood (2-20 μl) on a nitrocellulose strip con-
taining monoclonal antibodies, which react with parasite
specific antigens available in the blood of infected
patients to give visible, diagnostic and control bands
[13]. Despite variability observed in field studies con-
ducted in different settings [15-18], majority of RDTs
have high sensitivity and specificity (>90%) at a parasi-
taemia >100 asexual parasites/μl [13]. The accuracy
(sensitivity and specificity) of RDTs is mostly dependent
on the parasite species, transmission intensity, parasite
density, amount of circulating antigens, local poly-
morphisms of target antigen and persistence of antigens
after treatment [12,14].
Previous genetic studies of malaria parasites have lar-
gely relied on extraction of DNA from samples blotted
on filter papers [19,20]. The filter papers have usually
been easily sampled, for instance as part of drug efficacy
trials and general assessments of malaria epidemiology
and thus been a reliable source of parasite DNA. How-
ever, recently it has become increasingly difficult to
obtain parasite samples due to declining malaria in most
areas of Tanzania resulting in fewer studies performed,
for instance drug efficacy studies. Moreover, the number
of parasite positive patients from ongoing trials further-
more limits the sample size available for genetic studies.
Despite the decrease in malaria prevalence, it is impor-
tant for instance to identify emerging drug resistance
and to update the molecular anti-malarial resistance
maps that are currently being drawn, using sensitive
molecular tools.
Alternatively, stained blood smears can be used to
recover DNA but the quality of DNA is often low com-
pared to filter papers or whole blood samples [21,22],
because the harsh fixation and coloration procedures
when preparing a Giemsa-stained smear may hamper
extraction and amplification. A study which was con-
ducted in French Guiana showed that parasite DNA
could be recovered from fresh and archived RDTs [23].
However, more elaborate studies have not been con-
ducted under different epidemiological and climatic set-
tings to confirm if it is practically possible to recover
parasite or human DNA from RDTs (either fresh tests
or after extended storage). On the other hand, using
RDT widely, even at the community level, is an obvious
opportunity to obtain blood for diagnosis as well as sto-
rage, and later analysis for detection of resistance gene
mutations or co-morbidities. Filter paper is widely used
for the latter purpose, but not for diagnosis. Further-
more, the World Health Organization (WHO) recom-
mendations for performing quality assurance (QA) of
RDTs requires among other things, that RDTs should
be monitored in the field by comparing the results of
RDTs and reference microscopy monthly (for 20 blood
smears with positive RDT results and 20 with negative
results from selected sentinel sites) [24]. However, stu-
dies conducted to assess RDT implementation and QC
monitoring strategies in malaria endemic areas have
revealed that these recommendation cannot be attained
due to lack of high quality diagnostic services by micro-
scopy [17,25], and thus different strategies such as using
DNA extracted from RDTs for detection of malaria
parasites will be needed to achieve the intended goal
[17,24,25].
This study was therefore conducted to establish if suf-
ficient parasite DNA could be successfully extracted
from different types of fresh and archived RDTs (stored
at room temperature in the field/laboratory without any
preservatives), and used for molecular analyses. It also
explored the potentials of using RDTs as source of
DNA for detection of malaria parasites as part of QC
testing once the tests will be widely deployed in most
health facilities in Tanzania. It is expected that availabil-
ity of used RDTs will make it possible to obtain suffi-
cient parasite samples and utilize them as sources of
DNA for different molecular studies of malaria parasites
and supporting the NMCP to perform QC testing of the
RDTs that will be deployed in the field.
Methods
Study site and sampling
This study was conducted at Amani Biomedical Research
Laboratory (AMBRELA) of the National Institute for
Medical Research (NIMR) at Tanga Centre in Tanga
region, northeastern Tanzania. Archived RDTs were
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obtained from ongoing studies in Muheza (Interactions
between ACT for malaria and anti-retrovirals for
HIV/AIDS in co-infected patients in Muheza district,
Tanzania - InterACT project) and Korogwe [Passive case
detection of fevers using community owned resource
persons - CORPs (Ishengoma et al, personal communica-
tion)] districts of Tanga region, Tanzania.
Samples and laboratory analysis
A hyper-parasitaemic blood sample (with a parasite den-
sity of 131,260 asexual parasites/μl) obtained from a
patient attended at Tumaini Health Centre in Tanga
was initially diluted to 1,000 asexual parasites/μl with
whole blood donated by uninfected donor (with blood
group O+) and serially diluted (two fold dilutions in tri-
plicate) to 0.01 asexual parasites/μl. About 10 μl of the
diluted samples were blotted on RDTs according to
manufacturers’ instructions (ParaHIT®f, Span Diagnos-
tics - Surat, India). One set of the RDTs obtained from
the serially diluted samples was immediately used for
DNA extraction while two sets were stored at room
temperature for a period of one month; one of these
had silica preservatives added.
Before DNA extraction, the RDTs cassettes were
opened using a sterile scissors and forceps, and the
nitrocellulose strips were taken out. The strips were cut
into two pieces and the portions containing the sample
blotting site were used for extraction. The portions of
RDTs that were used for DNA extraction were incu-
bated in 0.5% saponin (in 1X phosphate buffered saline)
over-night at room temperature. DNA extraction was
performed as for filter papers using Chelex-100 method
as previously described [26]. The extraction process was
similar for the three sets of RDTs (either immediately or
after storage at room temperature for one month, with/
without silica preservatives) and DNA was amplified
using a nested PCR method for Plasmodium species
detection according to Snonou et al [27]. Amplified pro-
ducts were visualized on 2% agarose gel.
A total of 165 archived RDTs were tested to confirm if
DNA can be equally obtained from archived RDTs used
for patients’ diagnosis under routine clinical settings.
The same RDTs were used to assess if they could be uti-
lized as a source of DNA for detection of malaria para-
sites as part of QC testing of RDTs that will be
deployed and used for malaria diagnosis at all levels of
health care delivery system in Tanzania. The current
QC testing of RDTs requires that 20 blood smears pre-
pared by health workers at selected health facilities from
patients with positive and 20 from those with negative
RDT results should be examined by experienced techni-
cians at a reference laboratory. However, in health facil-
ities without the capacity for malaria diagnosis by
microscopy, health workers cannot prepare blood
smears of desirable quality and thus, archived RDTs can
potentially be employed as an alternative to microscopy
by using DNA extracted from such RDTs to detect
malaria parasites. To test if DNA obtained from
archived RDTs can be used for detection of molecular
markers of anti-malarial drug resistance, DNA from one
set of the serial dilutions and 10 archived RDTs were
used for detection of parasite genotypes in the Pfdhfr
gene which is a marker of pyrimethamine resistance
using the method described by Alifrangis et al [28]
The archived RDT samples included 71 RDTs (posi-
tive for both RDT and microcopy) collected at health
facilities in Muheza and Korogwe districts and stored
without any preservatives at room temperature (tem-
perature ranging from 25 - 34°C). Out of these, 26
RDTs were obtained from patients enrolled in InterACT
project in Muheza (on Paracheck Pf®, Orchid Biomedi-
cal Systems - Mumbai, India) while 45 were from
patients attended by CORPs in Korogwe district [on
ParaHIT®f Span Diagnostics - Surat, India (Ishengoma
et al, personal communication)]. Other 94 RDT samples
(on ParaHIT®f), included 24 RDT false positive (positive
by RDT but negative by microscopy), 63 false negatives
(negative by RDTs but positive by microscopy) and
seven negative samples (negative by both RDTs and
microcopy) obtained from a cross-sectional survey con-
ducted in May 2010 in four villages in Muheza district
where high level of false positive and negative RDT
results were observed in previous surveys (Ishengoma et
al, personal communication). All 165 RDT samples
were stored at room temperature in the field or labora-
tory for a duration of 6 - 95 days (Table 1). DNA
extraction and PCR genotyping were performed as in
the previous assays mentioned above on individual tubes
or 96-well plates depending on the number of samples.
Results
The minimum parasite detection limit of RDTs for the
diluted samples was 10 asexual parasites/μl. DNA was
successfully amplified from all of the three sets of RDTs
containing the dilution series. RDT samples stored at
room temperature for one month either with or without
silica gels were amplified equally well, as fresh RDTs
analysed immediately after blotting. The minimum para-
site detection limit of PCR for all three sets of diluted
samples was <1 asexual parasite/μl (Figure 1A and 1B).
Table 1 shows the results of PCR amplification suc-
cess for DNA extracted from different types of RDTs.
Successful amplification was obtained from most of the
microscopically positive samples whereby, 70 (98.6%)
out of 71 samples, which were positive by both micro-
scopy and RDTs were detected to be positive by PCR
(Figure 2A and 2B). Out of these, 26 (100%) RDTs
were Paracheck Pf® and 44(97.8%) were ParaHIT®f
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(Table 1). One positive RDT sample (ParaHIT®f),
which failed to amplify by PCR, had a low parasitaemia
detected by microscopy (one asexual parasite/200WBCs
equivalent to 40 asexual parasites/μl). Fifty-two (82.5%)
of the 63 false negative RDTs (which were negative by
RDTs, but positive by microscopy as a gold standard)
were positive by PCR. Eleven (17.4%) of the 63 false
negative RDT samples which failed to amplify by PCR
had low parasite density detected by microscopy (less
than 100 asexual parasites/μ; ranged from 16-80 asexual
parasites/μl).
Detection of microscopically negative samples was
equally successful whereby, 20 out of 24 (83.3%) RDT
false positive samples (which were positive by RDTs but
negative by microscopy) were confirmed to be negative
by PCR. Fourteen out of the 20 RDT false positive sam-
ples with negative PCR results were obtained from indi-
viduals who had taken anti-malarials (within seven days)
before the survey. All seven negative RDTs (negative by
both RDTs and microscopy) were also negative by PCR
(Table 1). Detection of parasite genotypes for Pfdhfr
gene as a marker of pyrimethamine resistance using
Table 1 PCR amplification success of DNA extracted from different types/brand of archived RDTs
Category of RDTs sampled No. of RDTs Type/brand of RDT Mean storage duration in days(range) PCR results
Positive (%) Negative (%)
True positive: RDT +ve/BS +ve 26 Paracheck Pf® 28(7-58) 26(100) 0(0)
True positive: RDT +ve/BS +ve 45 ParaHIT ®f 47(6-95) 44(97.8) 1(2.2)
False negative: RDT -ve/BS +ve 63 ParaHIT ®f 60(61-66) 52(82.5) 11(17.4)*
False positive: RDT +ve/BS -ve 24 ParaHIT ®f 60(55-66) 4(16.7) 20(83.3)
True negative: RDT -ve/BS -ve 7 ParaHIT ®f 65(63-69) 0(0) 7(100)
RDT = Rapid Diagnostic Test, BS = Blood smear, +ve = positive and -ve = negative.
*These samples had low parasite density detected by microscopy (less than 100 asexual parasites/μ; ranged from 16-80 asexual parasites/μl).
1 2 3 4 5 6 7 8 9 10 11 12 13 282714 15 16 17                       18 19 20 21 22 23 24 25 26
A
LM
1 2 3 4 27 285 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
B
LM
Figure 1 Pictures of agarose gels showing PCR products of DNA obtained from a hyper-parasitaemic sample which was blotted on
RDTs after making two fold serial dilutions (from 1000 to 0.01 asexual parasites/μl) and extracted after storage at room temperature
for 30 days with (A) or without (B) silica gels as preservatives. Lanes 1-22 = DNA from serially diluted samples, 23-26 = positive controls
(3D7 strain, 7g8 strain, patient sample with 1000 asexual parasites/μl, field sample on filter paper), 27-28 = negative controls and LM = 50 pb
ladder marker.
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DNA extracted from RDTs was also successful and the
results were similar to those observed when DNA was
obtained from other sources such as cultured parasites
or filter papers.
Discussion
Previously, malaria has consecutively been shown to be
the main cause of morbidity and mortality in Tanga
region, as for the rest of Tanzania [29-31]. However,
recently a drastic decline in the burden of malaria in
this region has been reported [5]; (Ishengoma et al,
personal communication) and most likely, the decline is
apparent in other parts of Tanzania as well (NMCP,
Unpublished data). However, because of this current
positive trend, recruitment of malaria positive patients
for various studies, such as malaria drug efficacy trials
has proved to be difficult. Since the region has been
known as a hotspot for the emergence of anti-malarial
drug resistance in Eastern Africa [32-36], it is of para-
mount importance to continue the surveillance of
in-vivo efficacy of principal anti-malarial drugs in the
region. Research-wise, this is furthermore affecting the
ability to obtain sufficient number of malaria parasite
samples for different molecular studies such as studies
on surveillance of molecular markers of anti-malarial
drug resistance.
In this context, the study presented here has shown
that archived RDTs used for malaria diagnosis in routine
practice can be used as an alternative source of DNA for
detection of malaria parasites and other molecular ana-
lyses. The RDTs can also be used as source of DNA as
part of QC testing of RDTs instead of microscopic
examination of Giemsa-stained blood smears, by com-
paring RTD results produced by health workers with
those obtained in the laboratory based on detection of
malaria parasite by PCR. Thus, after deployment of
RDTs in the field, archived RDTs can also be used for
QC of RDTs in addition to using Giemsa-stained blood
smears, particularly in health facilities without capacity
for performing malaria diagnosis by microscopy or lack-
ing the skills and experience to prepare good blood
smears as recently shown in Eastern Tanzania by
McMorrow and colleagues [17,25].
Storage of RDTs (that were prepared in the labora-
tory) for one month either with or without silica gel as
preservatives did not affect the quality of extracted DNA
as determined by the detection limit of PCR in the
diluted samples and band intensity of amplified products
Figure 2 Selected pictures of agarose gels showing PCR amplification of DNA obtained from 29 of the 71 archived positive RDTs that
were used for patients’ diagnosis in Muheza and Korogwe districts. 2A: lanes 1-18 = field samples (16 from InterACT in Muheza in lanes 1-
13 and 16-18, and 2 from Korogwe in lanes 14-15), 19-22 = positive controls (3D7strain, FCR3 strain, field sample on filter paper and patient
sample with 1000 asexual parasites/μl), 23-24 = negative controls; LM = 50 bp ladder marker 2B: lanes 1-11 = field samples (10 from InterACT in
1-10 and 1 from Korogwe in lane 11); 12-15 = positive controls (3D7 strain, FCR3 strain, field sample on filter paper and patient sample with
1000 asexual parasites/μl), 16-17 = negative controls and LM = 50 bp ladder marker.
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in comparison to known standard DNA samples which
were used as control. Similarly, field samples stored at
room temperature without preservatives for over 3
months were equally amplified. However, the impact of
long term storage of RDTs beyond this duration on the
quantity and quality of DNA is not clearly known, parti-
cularly if they are stored at room temperature without
preservatives and under high ambient temperature, and
humidity (as in most parts of Tanzania) which support
growth of moulds that can degrade the parasite DNA.
The period of three months or more shown in this and
a previous study [23] should be sufficient to have the
RDTs delivered to the laboratory even from the most
remotely located parts of Tanzania.
Both types of PfHRP-2 based RDTs (ParaHIT®f and
Paracheck Pf®) examined provided DNA of sufficient
quality with similar amplification success although the
quantity of DNA was not assessed. This is in concor-
dance to a previous study which showed that the type/
brand of RDTs did not affect the quality of extracted
DNA [23]. Furthermore, the technique proved useful in
examining conflicting diagnostic outcomes between
microscopy and RDTs. RDT false positive samples
showed similar results between PCR and microscopy
indicating that most of the samples that were microsco-
pically negative but positive by RDTs were actually
negative. False positive results by PfHRP-2 based RDTs
are commonly observed due to persistence of the anti-
gens for over 30 days after clearance of parasites follow-
ing treatment [37]. Among the 24 individuals with false
positive RDT results, 14 had taken anti-malarials within
seven days before the study; indicating that they may
still had persistent PfHRP-2 antigens in their blood.
PCR analysis of false negative samples showed conflict-
ing results regarding a subset of samples (11 samples)
initially identified by microscopy as positive (but nega-
tive by RDTs) and found to be negative by PCR. This
could be due to low parasite density since all of these
samples had < 100 asexual parasites/μl which is the
lowest detection limit of most of the RDTs and also
within the lower detection limit of microscopy [13].
Conclusion
This study showed that DNA can be extracted from
routinely used and archived RDTs, and successfully
amplified by PCR; thus providing an alternative source
of DNA for detection of malaria parasites and possibly
other molecular analyses such as surveillance of parasite
resistance to anti-malarial drugs and monitoring of insi-
dious parasite reservoirs in different interventions, such
as malaria elimination programmes. Furthermore, the
RDTs can be used for QC testing of RDTs deployed in
the field for malaria diagnosis based on comparing the
results obtained by PCR genotyping of DNA extracted
from archived RDTs with the test results produced by
health workers, particularly from remotely located
health facilities without the capacity of microscopic
examination of blood smears. Thus, availability of
archived RDTs after the tests are deployed in all health
facilities in Tanzania as planned by the Ministry of
Health and Social Welfare will provide a good source of
parasite DNA for laboratory studies.
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